Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs MOREPEN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA MOREPEN LABS SAMRAT PHARMA/
MOREPEN LABS
 
P/E (TTM) x 21.1 30.8 68.4% View Chart
P/BV x 2.1 4.8 43.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SAMRAT PHARMA   MOREPEN LABS
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-24
MOREPEN LABS
Mar-24
SAMRAT PHARMA/
MOREPEN LABS
5-Yr Chart
Click to enlarge
High Rs60456 1,072.4%   
Low Rs32025 1,262.8%   
Sales per share (Unadj.) Rs911.333.1 2,755.6%  
Earnings per share (Unadj.) Rs7.01.9 370.3%  
Cash flow per share (Unadj.) Rs9.12.5 357.3%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs210.316.6 1,269.1%  
Shares outstanding (eoy) m3.09511.17 0.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.2 41.1%   
Avg P/E ratio x66.021.6 305.6%  
P/CF ratio (eoy) x50.816.0 316.7%  
Price / Book Value ratio x2.22.5 89.1%  
Dividend payout %14.30-   
Avg Mkt Cap Rs m1,42820,879 6.8%   
No. of employees `000NANA-   
Total wages/salary Rs m111,815 0.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,81616,904 16.7%  
Other income Rs m14140 9.9%   
Total revenues Rs m2,83017,044 16.6%   
Gross profit Rs m251,586 1.6%  
Depreciation Rs m6335 1.9%   
Interest Rs m737 18.5%   
Profit before tax Rs m251,354 1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4388 0.9%   
Profit after tax Rs m22966 2.2%  
Gross profit margin %0.99.4 9.3%  
Effective tax rate %14.228.6 49.5%   
Net profit margin %0.85.7 13.4%  
BALANCE SHEET DATA
Current assets Rs m1,0268,890 11.5%   
Current liabilities Rs m5644,020 14.0%   
Net working cap to sales %16.428.8 56.9%  
Current ratio x1.82.2 82.2%  
Inventory Days Days1116 70.2%  
Debtors Days Days898702 128.0%  
Net fixed assets Rs m1924,042 4.7%   
Share capital Rs m311,022 3.0%   
"Free" reserves Rs m6197,450 8.3%   
Net worth Rs m6508,472 7.7%   
Long term debt Rs m034 0.0%   
Total assets Rs m1,21712,932 9.4%  
Interest coverage x4.737.5 12.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x2.31.3 177.0%   
Return on assets %2.37.8 30.2%  
Return on equity %3.311.4 29.2%  
Return on capital %4.916.4 30.2%  
Exports to sales %2.037.8 5.4%   
Imports to sales %83.532.0 261.1%   
Exports (fob) Rs m586,388 0.9%   
Imports (cif) Rs m2,3505,405 43.5%   
Fx inflow Rs m586,388 0.9%   
Fx outflow Rs m2,3505,584 42.1%   
Net fx Rs m-2,293803 -285.5%   
CASH FLOW
From Operations Rs m94734 12.8%  
From Investments Rs m-4-833 0.5%  
From Financial Activity Rs m-11252 -215.2%  
Net Cashflow Rs m-22-47 46.5%  

Share Holding

Indian Promoters % 49.0 35.7 137.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 3.8 85.5%  
FIIs % 0.0 2.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.1 64.4 79.3%  
Shareholders   6,984 430,929 1.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs MOREPEN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs MOREPEN LABS Share Price Performance

Period SAMRAT PHARMA MOREPEN LABS S&P BSE HEALTHCARE
1-Day -1.21% 1.15% 1.23%
1-Month -7.35% -4.51% -0.24%
1-Year 17.79% 70.39% 43.62%
3-Year CAGR 22.75% 16.16% 20.35%
5-Year CAGR 36.81% 34.70% 26.24%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the MOREPEN LABS share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 49.0% stake in the company. In case of MOREPEN LABS the stake stands at 35.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of MOREPEN LABS.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 14.3%.

MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of MOREPEN LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.